Supraglottic airway devices for surfactant treatment: systematic review and meta-analysis

Nicola Veronese, Nicola Veronese, Cavicchioli Paola, Francesco Cavallin, Massimo Micaglio, Maria Grazia Calevo, Daniele Trevisanuto

Risultato della ricerca: Articlepeer review

5 Citazioni (Scopus)

Abstract

Objective: To compare surfactant administration via supraglottic airway device (SAD) vs. nasal CPAP alone or INSURE. Study design: A systematic search of PubMed, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials and Clinicaltrials.gov was performed. Articles meeting inclusion criteria (RCT, surfactant administration via SAD, laryngeal mask, I-gel) were assessed Results: Five RCTs were eligible. Surfactant administration via SAD reduced the need for intubation/mechanical ventilation (RR 0.57, 95%CI 0.38–0.85) and short-term oxygen requirements (MD −8.00, 95%CI −11.09 to −4.91) compared to nCPAP alone. Surfactant administration via SAD reduced the need for intubation/mechanical ventilation (RR 0.43, 95%CI 0.31–0.61), but increased short-term oxygen requirements (MD 3.10, 95%CI 0.51–5.69) compared to INSURE approach. Conclusions: In preterm infants with RDS, surfactant administration via SAD reduces the need for intubation/mechanical ventilation. Overall, available literature includes few, small, poor-quality studies. Surfactant administration via SAD should be limited to clinical trials. © 2018, Springer Nature America, Inc.
Lingua originaleEnglish
pagine (da-a)173-183
Numero di pagine11
RivistaJournal of Perinatology
Volume39
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cita questo